Quality is more than a commitment - It’s in our DNA. Pure combines Swiss quality and cannabis experience with state-of-the-art technologies, improving cannabis with every step we take.
Switzerland is renowned for its quality and attention to detail. It is generally known as a hub for various industries (finance, education, research & legal). This continuously attracts highly educated individuals from around the world, providing Pure Holding with the opportunity to select the best of the best to be a part of our journey. Moreover, Switzerland has one of the most mature hemp markets in the world. The “Swiss Hemp Bill of 2011” was a visionary move that facilitated legal investments and innovation into the hemp industry before any other country in the world. That's why Switzerland's innovation, knowledge, genetics, and technologies in the cannabis field are years ahead of any other country.
The Pure Group maintains an analytics platform with a top of the line infrastructure, constantly validated in accordance to GLP guidelines.
Our High-Performance Liquid Chromatography (UPLC) and Gas Chromotrography (GC) platforms have been optimized for extreme accuracy as well as high throughput. Together these allow for the perfect quantification of all major cannabinoids and terpenes of the cannabis plant.
The laboratory fulfills the dual task of providing the Quality Control framework for Pure Production AG, monitoring cannabinoid levels within the production line and end products, and to support Puregene AG in its research and breeding goals.
Heading up Pure’s analytics department is Dr. Martina Zanella (PhD in Plant Biochemistry from the Swiss Federal Institute of Technology (ETH).
Pure Holding operates with an integrated management system (quality management, hygiene, occupational safety). The entire system is based on ISO9001, GMP and Swiss Certified Cannabis SCC and is checked and monitored by internal audits.
Swiss Certified Cannabis (SCC)
the newly created label
SWISO - ISO 9001
Pure Production AG
and DEOM Production AG
Good Distribution Practice
Pure Pharma AG